Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.560
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.560
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Adial Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 5.18 | 5.06 | 5.62 | 8.91 | 9.3 | |
| Research & Development | 2.62 | 3.23 | 1.27 | 1.95 | 8.4 | |
| Operating Expenses | 7.8 | 8.28 | 6.89 | 10.86 | 17.69 | |
| Operating Income | -7.8 | -8.28 | -6.89 | -10.86 | -17.69 | |
| Interest & Investment Income | 0.15 | 0.18 | 0.07 | 0.06 | 0.01 | |
| Earnings From Equity Investments | -0.49 | -0.55 | -0.19 | - | - | |
| Other Non Operating Income (Expenses) | 0.16 | -0.08 | 0.01 | - | 0.02 | |
| EBT Excluding Unusual Items | -7.98 | -8.73 | -7 | -10.8 | -17.67 | |
| Merger & Restructuring Charges | - | - | - | - | -0.05 | |
| Asset Writedown | - | - | - | - | -1.55 | |
| Other Unusual Items | - | -4.46 | - | - | -0.25 | |
| Pretax Income | -7.98 | -13.2 | -7 | -10.8 | -19.52 | |
| Income Tax Expense | - | - | - | - | -0.09 | |
| Earnings From Continuing Operations | -7.98 | -13.2 | -7 | -10.8 | -19.42 | |
| Earnings From Discontinued Operations | - | - | 1.88 | -1.94 | - | |
| Net Income | -7.98 | -13.2 | -5.12 | -12.73 | -19.42 | |
| Net Income to Common | -7.98 | -13.2 | -5.12 | -12.73 | -19.42 | |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 244.55% | 240.54% | 42.25% | 34.69% | 49.15% | |
| EPS (Basic) | -11.93 | -68.01 | -89.91 | -317.81 | -653.06 | |
| EPS (Diluted) | -11.93 | -68.01 | -89.91 | -317.81 | -653.06 | |
| Free Cash Flow | -6.49 | -6.92 | -6.81 | -11.19 | -12.01 | |
| Free Cash Flow Per Share | -9.71 | -35.67 | -119.45 | -279.23 | -403.94 | |
| EBITDA | -7.8 | -8.28 | -6.89 | -10.86 | -17.69 | |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0.01 | |
| EBIT | -7.8 | -8.28 | -6.89 | -10.86 | -17.69 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.